D.A. Davidson & CO. grew its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 8.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 156,522 shares of the company’s stock after acquiring an additional 11,601 shares during the quarter. D.A. Davidson & CO.’s holdings in Express Scripts were worth $9,910,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of ESRX. Burt Wealth Advisors lifted its holdings in shares of Express Scripts by 11.4% in the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after buying an additional 174 shares during the period. CKW Financial Group lifted its holdings in shares of Express Scripts by 20.0% in the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after buying an additional 300 shares during the period. IHT Wealth Management LLC lifted its holdings in shares of Express Scripts by 8.1% in the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock valued at $128,000 after buying an additional 145 shares during the period. FNY Partners Fund LP acquired a new position in shares of Express Scripts in the 1st quarter valued at about $138,000. Finally, First Personal Financial Services increased its stake in shares of Express Scripts by 199.1% in the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after purchasing an additional 1,400 shares in the last quarter. 88.44% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the sale, the director now owns 11,500 shares of the company’s stock, valued at $735,195. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.
Express Scripts Holding Company (NASDAQ ESRX) opened at $67.41 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts Holding Company has a twelve month low of $55.80 and a twelve month high of $75.99. The company has a market capitalization of $38,840.00, a P/E ratio of 9.92, a P/E/G ratio of 1.00 and a beta of 0.88.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The company had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. During the same period in the prior year, the firm earned $1.74 earnings per share. The firm’s revenue was down 2.9% compared to the same quarter last year. equities analysts anticipate that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.
ESRX has been the subject of several recent analyst reports. Jefferies Group set a $72.00 price target on Express Scripts and gave the company a “buy” rating in a research note on Tuesday, August 29th. Mizuho set a $67.00 price objective on Express Scripts and gave the stock a “hold” rating in a research note on Tuesday, October 24th. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday. Royal Bank Of Canada initiated coverage on Express Scripts in a research note on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 price objective for the company. Finally, UBS lowered Express Scripts from a “market perform” rating to an “underperform” rating in a research note on Monday, October 9th. Six equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Express Scripts has a consensus rating of “Hold” and an average price target of $70.67.
TRADEMARK VIOLATION WARNING: This piece was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/12/08/d-a-davidson-co-has-9-91-million-holdings-in-express-scripts-holding-company-esrx.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.